If a company like Merck (MRK) is going to overcome problems with a lot its drugs going "off patent" it is going to have to come up with some new ways to make money. One is to offer its drugs over-the-counter, which should boost sales.
According to The Associated Press "the government is questioning if too many of the wrong people will take cholesterol-lowering Mevacor if it’s sold without a prescription, days before Merck & Co. makes its third try to move the drug over the counter."
Surveys of potential patients show that many are not sure when and how to use the drug. That is probably a good reason to keep doctors as the gate-keepers for Mevacor.
Douglas A. McIntyre
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
